WallStreetZenWallStreetZen

NASDAQ: ACHV
Achieve Life Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACHV

Based on 3 analysts offering 12 month price targets for Achieve Life Sciences Inc.
Min Forecast
$11.00+144.44%
Avg Forecast
$16.33+262.96%
Max Forecast
$20.00+344.44%

Should I buy or sell ACHV stock?

Based on 3 analysts offering ratings for Achieve Life Sciences Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACHV stock forecasts and price targets.

ACHV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-03-05

1 of 1

Forecast return on equity

Is ACHV forecast to generate an efficient return?
Company
N/A
Industry
-71.71%
Market
19.68%

Forecast return on assets

Is ACHV forecast to generate an efficient return on assets?
Company
N/A
Industry
7.14%

ACHV revenue forecast

What is ACHV's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$48.5M

ACHV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACHV$4.50$16.33+262.96%Strong Buy
ZURA$3.48$16.00+359.77%Buy
CAPR$4.82$24.00+397.93%Strong Buy
MDWD$16.41$28.00+70.63%Buy
CRVO$24.29$65.00+167.60%Strong Buy

Achieve Life Sciences Stock Forecast FAQ

Is Achieve Life Sciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ACHV) stock is to Strong Buy ACHV stock.

Out of 3 analysts, 2 (66.67%) are recommending ACHV as a Strong Buy, 1 (33.33%) are recommending ACHV as a Buy, 0 (0%) are recommending ACHV as a Hold, 0 (0%) are recommending ACHV as a Sell, and 0 (0%) are recommending ACHV as a Strong Sell.

If you're new to stock investing, here's how to buy Achieve Life Sciences stock.

What is ACHV's revenue growth forecast for 2025-2025?

(NASDAQ: ACHV) Achieve Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Achieve Life Sciences's revenue in 2024 is $0.

In 2025, ACHV is forecast to generate $1,661,217,684 in revenue, with the lowest revenue forecast at $1,661,217,684 and the highest revenue forecast at $1,661,217,684.

What is ACHV's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: ACHV) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 7.14%.

What is ACHV's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ACHV price target, the average ACHV price target is $16.33, with the highest ACHV stock price forecast at $20.00 and the lowest ACHV stock price forecast at $11.00.

On average, Wall Street analysts predict that Achieve Life Sciences's share price could reach $16.33 by Apr 17, 2025. The average Achieve Life Sciences stock price prediction forecasts a potential upside of 262.96% from the current ACHV share price of $4.50.

What is ACHV's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: ACHV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.